pubmed-article:12832314 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12832314 | lifeskim:mentions | umls-concept:C0025598 | lld:lifeskim |
pubmed-article:12832314 | lifeskim:mentions | umls-concept:C0009429 | lld:lifeskim |
pubmed-article:12832314 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
pubmed-article:12832314 | lifeskim:mentions | umls-concept:C0246689 | lld:lifeskim |
pubmed-article:12832314 | lifeskim:mentions | umls-concept:C0903898 | lld:lifeskim |
pubmed-article:12832314 | lifeskim:mentions | umls-concept:C0556895 | lld:lifeskim |
pubmed-article:12832314 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:12832314 | pubmed:dateCreated | 2003-6-30 | lld:pubmed |
pubmed-article:12832314 | pubmed:abstractText | An open-label, parallel-group, randomized, multicenter trial was conducted to compare efficacy and safety of repaglinide versus nateglinide, when used in a combination regimen with metformin for treatment of type 2 diabetes. | lld:pubmed |
pubmed-article:12832314 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12832314 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12832314 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12832314 | pubmed:language | eng | lld:pubmed |
pubmed-article:12832314 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12832314 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12832314 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12832314 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12832314 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12832314 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12832314 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12832314 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12832314 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12832314 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12832314 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12832314 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12832314 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12832314 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12832314 | pubmed:month | Jul | lld:pubmed |
pubmed-article:12832314 | pubmed:issn | 0149-5992 | lld:pubmed |
pubmed-article:12832314 | pubmed:author | pubmed-author:RaskinPhilipP | lld:pubmed |
pubmed-article:12832314 | pubmed:author | pubmed-author:McGillJanetJ | lld:pubmed |
pubmed-article:12832314 | pubmed:author | pubmed-author:HollanderPris... | lld:pubmed |
pubmed-article:12832314 | pubmed:author | pubmed-author:HalePaula MPM | lld:pubmed |
pubmed-article:12832314 | pubmed:author | pubmed-author:KlaffLeslieL | lld:pubmed |
pubmed-article:12832314 | pubmed:author | pubmed-author:SouthStephen... | lld:pubmed |
pubmed-article:12832314 | pubmed:author | pubmed-author:KhutoryanskyN... | lld:pubmed |
pubmed-article:12832314 | pubmed:author | pubmed-author:Repaglinide... | lld:pubmed |
pubmed-article:12832314 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12832314 | pubmed:volume | 26 | lld:pubmed |
pubmed-article:12832314 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12832314 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12832314 | pubmed:pagination | 2063-8 | lld:pubmed |
pubmed-article:12832314 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:meshHeading | pubmed-meshheading:12832314... | lld:pubmed |
pubmed-article:12832314 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12832314 | pubmed:articleTitle | Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin. | lld:pubmed |
pubmed-article:12832314 | pubmed:affiliation | Departemtn of Internal Medicine, Southwestern Medical Center, University of Texas, Dallas, Texas 75390-8858, USA. philip.raskin@utsouthwestern.edu | lld:pubmed |
pubmed-article:12832314 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12832314 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:12832314 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:12832314 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:12832314 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:12832314 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12832314 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12832314 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12832314 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12832314 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12832314 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12832314 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12832314 | lld:pubmed |